Comparison of Jumbo and Hot Biopsy Forceps
Launched by CAMLICA ERDEM HOSPITAL · Jul 10, 2014
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
* Exclusion criteria were (i) having abnormal coagulation parameters and thrombocytopenia, taking aspirin or other medications which could affect bleeding time, (ii) history of inflammatory bowel disease, (iii) pregnancy.
* One experienced endoscopist carried out all the procedures using the same techniques.
* If a diminutive polyp was detected during colonoscopy, and it was estimated that the polyp was eligible for the study, the patient was randomly assigned by the physician to one of the two forceps groups (hot biopsy versus jumbo forceps) using a flipping coin method. Polypectomy was th...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients found to have at least one diminutive polyp (measuring ≤ 5 mm).
- Exclusion Criteria:
- • Having abnormal coagulation parameters and thrombocytopenia
- • Taking aspirin or other medications which could affect bleeding time
- • History of inflammatory bowel disease
- • Pregnancy.
About Camlıca Erdem Hospital
Camlıca Erdem Hospital is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. Committed to enhancing treatment options and improving patient outcomes, the hospital employs state-of-the-art facilities and a multidisciplinary team of experienced professionals. By fostering collaboration among researchers, clinicians, and participants, Camlıca Erdem Hospital aims to contribute valuable insights to the medical community while ensuring the highest standards of safety and ethical practices in all its trial activities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials